Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Kiromic Biopharma (KRBP)
OTHER OTC:KRBP
Holding KRBP?
Track your performance easily
KRBP Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$0.16 - $3.78
Previous Close$1.4
Volume288.00
Average Volume (3M)3.03K
Market Cap
$2.16M
Enterprise Value$11.49M
Total Cash (Recent Filing)$4.05M
Total Debt (Recent Filing)$13.37M
Price to Earnings (P/E)―
Beta1.78
Next Earnings
May 10, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-19.77
Shares Outstanding1,545,920
10 Day Avg. Volume826
30 Day Avg. Volume3,032
Standard Deviation0.49
R-Squared0.04
Alpha-0.05
Financial Highlights & Ratios
Price to Book (P/B)-0.05
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit10.00T>
Enterprise Value/Ebitda-0.54
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
Kiromic Biopharma News
PremiumCompany Announcements
Kiromic BioPharma’s Strategic Financial Restructuring and Equity Shift
PremiumCompany Announcements
Kiromic Biopharma Outlines Vision in Stakeholder MeetingsPremiumCompany Announcements
Kiromic Biopharma Strikes $2M Convertible Debt Deal for Growth
Risk Analysis
Main Risk Category
Finance & CorporateFinancial and accounting risks. Risks related to the execution of corporate activity and strategy
Website Traffic
Sorry, No Data AvailableThere is no website visitor data available for this stock.
---
KRBP FAQ
What was Kiromic Biopharma’s price range in the past 12 months?
Kiromic Biopharma lowest stock price was $0.16 and its highest was $3.78 in the past 12 months.
What is Kiromic Biopharma’s market cap?
Currently, no data Available
When is Kiromic Biopharma’s upcoming earnings report date?
Kiromic Biopharma’s upcoming earnings report date is May 10, 2024 which is 142 days ago.
How were Kiromic Biopharma’s earnings last quarter?
Kiromic Biopharma released its earnings results on May 12, 2023. The company reported -$6.17 earnings per share for the quarter, missing the consensus estimate of N/A by -$6.17.
Is Kiromic Biopharma overvalued?
According to Wall Street analysts Kiromic Biopharma’s price is currently Overvalued.
Does Kiromic Biopharma pay dividends?
Kiromic Biopharma does not currently pay dividends.
What is Kiromic Biopharma’s EPS estimate?
Kiromic Biopharma’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Kiromic Biopharma have?
Kiromic Biopharma has 1,545,920 shares outstanding.
What happened to Kiromic Biopharma’s price movement after its last earnings report?
Kiromic Biopharma reported an EPS of -$6.17 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -0.415%.
Which hedge fund is a major shareholder of Kiromic Biopharma?
Currently, no hedge funds are holding shares in KRBP
---
Kiromic Biopharma Stock Smart Score
Unlock Smart Score
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Negative
20 days / 200 days
Momentum
382.75%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
-8.60%
Trailing 12-Months
Company Description
Kiromic Biopharma
Kiromic BioPharma Inc is a bio-technology company. The company is a gene editing which utilizes artificial intelligence and proprietary neural network platform with a therapeutic focus on immuno-oncology.
---
Technical Analysis
Aditxt, Inc.
―
Cellectar Biosciences
―
Oncternal Therapeutics
―
TRACON Pharmaceuticals
―
---